Here's Why Aligos Therapeutics (ALGS) Is a Great 'Buy the Bottom' Stock Now

Core Viewpoint - Aligos Therapeutics, Inc. (ALGS) has experienced an 8.1% decline in share price over the past two weeks, but a hammer chart pattern suggests a potential trend reversal due to increased buying interest and positive earnings estimates from analysts [1][2] Group 1: Technical Analysis - A hammer chart pattern formed in the last trading session indicates that the stock may have found support, suggesting a possible reversal of the downtrend [1] - The hammer pattern is characterized by a small candle body with a long lower wick, signaling that bears may have lost control over the price [1] - Hammer candles can appear on various timeframes and are used by both short-term and long-term investors, although they should be combined with other bullish indicators for confirmation [1] Group 2: Fundamental Analysis - There has been a positive trend in earnings estimate revisions for ALGS, with the consensus EPS estimate increasing by 12.6% over the last 30 days, indicating bullish sentiment among analysts [2] - ALGS holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [2] - The Zacks Rank serves as a timing indicator, suggesting that the company's prospects are improving, further supporting the potential for a turnaround in ALGS shares [2]